Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors

Sponsor and Collaborators     
Memorial Sloan-Kettering Cancer Center
Merck
Phoenix Children’s Hospital
Penn State Children’s Hospital
Johns Hopkins University
Sidney Kimmel Comprehensive Cancer Center
Children’s Hospital Colorado
University of Florida
Alberta Children’s Hospital
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Children’s Mercy Hospital & Clinics
All Children’s Hospital

Contacts
Tanya Trippett,, MD     212-639-8267     
Christine Pratilas, MD     212-639-3964     
             
Investigator    
Tanya Trippett, MD     
Memorial Sloan-Kettering Cancer Center     


Continue Reading

ClinicalTrials.gov Identifier
NCT01294670